The Collaborative Community on Ophthalmic Innovation Appoints Dr. Malvina Eydelman as CEO

The Collaborative Community on Ophthalmic Innovation (CCOI) is pleased to announce the appointment of Dr. Malvina Eydelman as Chief Executive Officer (CEO). Dr. Eydelman brings a wealth of experience and expertise to this role, having dedicated her career to advancing healthcare and improving patient outcomes.

Dr. Eydelman’s background includes three decades of leadership at the U.S. Food and Drug Administration (FDA), where she spearheaded innovative initiatives in medical product regulation. Her commitment to collaboration between industry, regulators, clinicians, and patients has been instrumental in bringing safe and effective innovations to market.

As a board-certified ophthalmologist with degrees from Harvard Medical School and Massachusetts Institute of Technology (M.I.T.), Dr. Eydelman has a deep understanding of medical product innovation. Throughout her career, she has led FDA teams in overseeing the safety and effectiveness of various medical devices, including ophthalmic technologies such as AI, Premium IOLs, MIGS, LASIK, and Bioelectronic Implants.

Dr. Eydelman’s expertise is widely recognized, and she serves on several government and professional committees. She is also a mentor and educator, sharing her knowledge with the next generation of innovators in ophthalmology.

In her new role as CEO of CCOI, Dr. Eydelman aims to drive groundbreaking clinical innovation and transform patient care on a global scale. She envisions CCOI as a catalyst for overcoming barriers to ophthalmic medical product innovation worldwide, establishing a framework that promotes the availability of innovative products on a global scale.

This strategic leadership appointment marks a significant milestone for CCOI as it continues to improve patient outcomes and advance solutions in ophthalmology. Dr. Eydelman’s leadership will undoubtedly shape a brighter future for ophthalmic healthcare globally.

The Collaborative Community on Ophthalmic Innovation (CCOI) is a dynamic forum dedicated to accelerating the development and adoption of ophthalmic medical products worldwide. By uniting stakeholders from various sectors, CCOI aims to address key barriers to innovation in the field of ophthalmology and ensure groundbreaking products reach patients in need.

In conclusion, Dr. Malvina Eydelman’s appointment as CEO of CCOI represents a pivotal moment for the organization and the field of ophthalmic innovation. Her expertise, leadership, and vision will drive forward solutions that improve global eye health and enhance patient care. Visit cc-oi.org for more information and to engage with CCOI’s mission of advancing ophthalmic medical product innovation worldwide.